| Literature DB >> 30705086 |
Peng Chen1, Yihe Hu2, Zhanzhan Li3.
Abstract
We searched several databases from the times of their inception to 20 December 2018. Randomized controlled trials and cohort studies that compared percutaneous endoscopic transforaminal discectomy (PETD) with percutaneous endoscopic interlaminar discectomy (PEID) were identified. We used a random-effects model to calculate the relative risks (RRs) of, and standardized mean differences (SMDs) between the two techniques, with 95% confidence intervals (CIs). Twenty-six studies with 3294 patients were included in the final analysis. Compared with PEID, PETD reduced the short-term (SMD -0.68; 95% CI -1.01, -0.34; P=0.000) and long-term (SMD -0.47; 95% CI -0.82, -0.12; P=0.000) visual analog scale scores, blood loss (SMD -4.75; 95% CI -5.80, -3.71; P=0.000), duration of hospital stay (SMD -1.86; 95% CI -2.36, -1.37; P=0.000), and length of incision (SMD -3.93; 95% CI -5.23, -2.62; P=0.000). However, PEID was associated with a lower recurrence rate (P=0.035) and a shorter operative time (P=0.014). PETD and PEID afforded comparable excellent- and good-quality data, long- and short-term Oswestry disability index (ODI) scores, and complication rates. PETD treated lumbar disc herniation (LDH) more effectively than PEID. Although PETD required a longer operative time, PETD was as safe as PEID, and was associated with less blood loss, a shorter hospital stay, and a shorter incision. PETD is the best option for patients with LDH.Entities:
Keywords: Lumbar disc herniation; meta-analysis; microendoscopic discectomy; percutaneous endoscopic lumbar discectomy
Mesh:
Year: 2019 PMID: 30705086 PMCID: PMC6379230 DOI: 10.1042/BSR20181866
Source DB: PubMed Journal: Biosci Rep ISSN: 0144-8463 Impact factor: 3.840
Figure 1Flow chart of study selection
Characteristics of included studies in the meta-analysis
| Author | Publication year | Age (PEID/PETD) | Study design | Sample size | Follow-up time (months) | Type | |
|---|---|---|---|---|---|---|---|
| PEID | PETD | ||||||
| Fang | 2012 | 43.5/45.8 | Retrospective | 40 | 40 | 6 | (1)(2)(3) |
| Le | 2014 | 37.2/38.4 | Prospective | 190 | 185 | 12 | (1)(2)(3) |
| Guan | 2014 | - | Prospective | 35 | 35 | 3 | - |
| Wu | 2009 | 4.5/45.8 | Prospective | 30 | 30 | 6 | (1)(2)(3) |
| Wu | 2015 | 38.5/41.3 | Prospective | 50 | 36 | 6 | (1)(2)(3) |
| Zhang | 2015 | 43.2/41.5 | Prospective | 30 | 30 | 26 | (3)(4) |
| Zhang | 2015 | 37.5/35.8 | Retrospective | 21 | 21 | 12 | (1)(2)(4) |
| Fu | 2014 | - | Prospective | 8 | 62 | 12 | (1)(2)(3)(4) |
| Zeng | 2015 | - | Prospective | 25 | 25 | 24 | - |
| Li | 2013 | 38.3/43.3 | Prospective | 212 | 208 | - | - |
| Li | 2015 | 51.5/51.6 | Retrospective | 50 | 50 | - | - |
| Yang | 2015 | 48.4/48.0 | Prospective | 82 | 57 | 3 | - |
| Tang | 2015 | - | Prospective | 38 | 38 | 24 | - |
| Zhao | 2012 | 39.4/43.2 | Retrospective | 245 | 261 | - | - |
| Chen | 2015 | - | Prospective | 25 | 13 | 13.5 | (3)(4) |
| Mao | 2015 | 37.5/37.8 | Retrospective | 35 | 30 | 12 | - |
| Yoon | 2012 | 45.9/56.5 | Retrospective | 37 | 35 | 6 | - |
| Sinkemani | 2015 | 44.2/41.5 | Retrospective | 50 | 36 | 14 | - |
| Liu | 2012 | - | Prospective | 25 | 13 | 13.5 | (3)(4) |
| Chen | 2018 | 64.1/64.2 | Prospective | 137 | 136 | 12 | (1)(2)(4) |
| Chen | 2018 | 40.7/40.2 | Prospective | 73 | 80 | 12 | (1)(2)(3)(4) |
| Huang | 2018 | 32.1/32.3 | Retrospective | 52 | 50 | 6 | (1)(2)(3)(4) |
| Ding | 2017 | 54.2/54.4 | Prospective | 40 | 40 | 3 | (1)(2)(3)(4) |
| Liu | 2017 | 69.2/68.9 | Prospective | 25 | 25 | 3 | (1)(2)(3)(4) |
| Liu | 2018 | 33.1/36.2 | Prospective | 63 | 60 | 24 | (1)(2)(3)(4) |
| Wu | 2017 | 38.7/40.8 | Retrospective | 40 | 40 | 12 | (1)(2)(3) |
(1) Central type, (2) Para central, (3) Intervertebral foramen, and (4) Far-lateral.
Comparison of pooled parameters between percutaneous endoscopic lumbar, transforaminal discectomy and interlaminar discectomy
| Parameters | Number of study | RR/SMD | 95% CI | Egger | Begg | ||
|---|---|---|---|---|---|---|---|
| Short-term VAS | 12 | 0.000 | −0.68 | −1.01, −0.34 | 0.000 | 0.012 | 0.002 |
| Long-term VAS | 11 | 0.000 | −0.47 | −0.82, −0.12 | 0.000 | 0.900 | 0.224 |
| Short-term ODI | 5 | 0.000 | −0.06 | −0.33, 0.22 | 0.691 | 0.306 | 0.951 |
| Long-term ODI | 7 | 0.000 | −0.15 | −0.36, 0.06 | 0.123 | 0.238 | 0.537 |
| Excellent and good rate | 13 | 0.015 | 1.02 | 0.97, 1.07 | 0.509 | 0.232 | 0.272 |
| Complication rate | 15 | 0.438 | 0.78 | 0.54, 1.13 | 0.185 | 0.149 | 0.400 |
| Recurrence rate | 11 | 0.128 | 1.90 | 1.04, 3.47 | 0.035 | 0.017 | 0.008 |
| Duration of operation | 18 | 0.000 | 0.70 | 0.14, 1.26 | 0.014 | 0.226 | 0.058 |
| Blood loss | 15 | 0.000 | −4.75 | −5.80, −3.71 | 0.000 | 0.273 | 0.235 |
| Length of incision | 8 | 0.000 | −3.93 | −5.23, −2.62 | 0.000 | 0.067 | 0.063 |
| Duration of hospital stay | 15 | 0.000 | −1.86 | −2.36, −1.37 | 0.000 | 0.081 | 0.038 |
Figure 2Comparison of short-term VAS between PETD and PEID
Figure 3Comparison of long-term VAS between PETD and PEID.
Figure 4Forest plot for short-term and long-term ODI between PETD and PEID
Comparison of short-term (A) and long-term (B) ODI between PETD and PEID.
Figure 5Forest plot for clinical outcomes
Comparisons of clinical outcomes between PETD and PEID: (A) excellent and good rate; (B) complication rate; (C) recurrence and residue rate.
Figure 6Forest plot for symptoms
Comparisons of duration of operation (A), blood loss (B), length of incision (C), and length of hospital stay (D).